Pro Pharmaceutical: Signed a five-year strategic cooperation framework agreement with Ti Technology.

Pro Pharmaceutical Co., Ltd. announced that it has recently signed a "Strategic Cooperation Framework Agreement" with Jitai Technology Co., Ltd., establishing a strategic partnership for long-term cooperation on projects related to CDMO and others. The cooperation includes CDMO service collaboration, potential capital and industrial synergy cooperation, and joint development of innovative drugs. This agreement is a framework agreement, does not involve substantive transactions, does not constitute a related party transaction, and does not constitute a major asset reorganization. The agreement is valid for five years and will not have a significant impact on the company's operating performance for the current year.